Introducción Los beneficios de la presión positiva continua en la vía aérea (CPAP) en pacientes con apnea obstructiva del sueño (AOS) no se alcanzan sin adhesión terapéutica (AT). La percepción de beneficio es uno de […]
Introduction and objective Teriflunomide is an oral immunomodulatory agent approved for the treatment of relapsing–remitting multiple sclerosis (RRMS). We examined teriflunomide outcomes in patients with RRMS under clinical practice conditions in Spain. Material and methods […]
Background Delayed cerebral ischemia is a common complication after aneurysmal subarachnoid hemorrhage, which accounts for high morbidity and mortality in these patients. Predictors for this complication's development are necessary to ensure the prevention and adequate […]
